MX1.AX ASX
Micro-X Limited
1W: +37.8%
1M: +153.1%
3M: +72.2%
YTD: -27.9%
1Y: -20.5%
3Y: -40.6%
5Y: -78.8%
A$0.06 ($0.04)
-0.01 (-9.68%)
Weekly Expected Move ±42.7%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
#12
of 20
Medical - Devices
Technical Signal Map
3 Bullish
3 Neutral
7 Bearish
MX1.AX
$50M
Micro-X Limited
BULLISH
+40
4DX.AX
$2.6B
4DMedical Limited
BULLISH
+84
CMP.AX
$50M
Compumedics Limited
BULLISH
+43
EPI.AX
$60M
Epiminder Limited
N/A
0
COV.AX
$50M
Cleo Diagnostics Ltd
N/A
0
HMD.AX
$50M
HeraMED Limited
NEUTRAL
-9
AVR.AX
$1.1B
Anteris Technologies Ltd
BEARISH
-50
EMV.AX
$150M
EMVision Medical Devices Ltd
BEARISH
-75
CYC.AX
$60M
Cyclopharm Limited
BEARISH
-84
PNV.AX
$620M
PolyNovo Limited
BEARISH
-91
SOM.AX
$70M
SomnoMed Limited
BEARISH
-91
COH.AX
$8.5B
Cochlear Limited
BEARISH
-100
CALZF
$430M
Polynovo Limited
BEARISH
-100
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| MX1.AX Micro-X Limited | $50M | -3.9 | -248.0 | -278.5 | -65.4 | -6.9 | 2 | BULLISH | -20.5 |
| 4DX.AX 4DMedical Limited | $2.6B | -10.4 | -190.0 | 71.2 | -1194.8 | 183.3 | 4 | BULLISH | 463.6 |
| CMP.AX Compumedics Limited | $50M | 250.0 | -5.2 | -8.1 | -0.2 | 20.1 | 4 | BULLISH | -17.5 |
| EPI.AX Epiminder Limited | $60M | — | — | — | — | — | — | N/A | — |
| COV.AX Cleo Diagnostics Ltd | $50M | — | — | — | — | — | — | N/A | — |
| HMD.AX HeraMED Limited | $50M | -13.6 | -414.6 | 1463.1 | — | -49.4 | 4 | NEUTRAL | 23.5 |
| AVR.AX Anteris Technologies Ltd | $1.1B | -2.9 | -165.5 | 7986.8 | -3467.6 | -34.8 | 5 | BEARISH | 88.1 |
| EMV.AX EMVision Medical Devices Ltd | $150M | -17.5 | -105.7 | -956.0 | — | -72.2 | 1 | BEARISH | -19.2 |
| CYC.AX Cyclopharm Limited | $60M | -2.8 | -79.8 | -118.1 | -50.2 | 27.4 | 3 | BEARISH | -53.9 |
| PNV.AX PolyNovo Limited | $620M | 86.3 | 25.2 | 18.9 | 10.0 | 60.5 | 7 | BEARISH | -37.6 |
| SOM.AX SomnoMed Limited | $70M | -24.0 | -13.2 | 10.2 | -6.4 | 29.0 | 6 | BEARISH | -60.8 |
| COH.AX Cochlear Limited | $8.5B | 57.7 | 29.9 | 34.3 | -1.2 | 11.4 | 6 | BEARISH | -57.3 |
| CALZF Polynovo Limited | $430M | 86.3 | 25.3 | 19.0 | 10.0 | 60.8 | 7 | BEARISH | -34.7 |
| MX1.AX Micro-X Limited | $50M | -3.9 | -248.0 | -278.5 | -65.4 | -6.9 | 2 | BULLISH | -20.5 |
| 4DX.AX 4DMedical Limited | $2.6B | -10.4 | -190.0 | 71.2 | -1194.8 | 183.3 | 4 | BULLISH | 463.6 |
| CMP.AX Compumedics Limited | $50M | 250.0 | -5.2 | -8.1 | -0.2 | 20.1 | 4 | BULLISH | -17.5 |
| EPI.AX Epiminder Limited | $60M | — | — | — | — | — | — | N/A | — |
| COV.AX Cleo Diagnostics Ltd | $50M | — | — | — | — | — | — | N/A | — |
| HMD.AX HeraMED Limited | $50M | -13.6 | -414.6 | 1463.1 | — | -49.4 | 4 | NEUTRAL | 23.5 |
| AVR.AX Anteris Technologies Ltd | $1.1B | -2.9 | -165.5 | 7986.8 | -3467.6 | -34.8 | 5 | BEARISH | 88.1 |
| EMV.AX EMVision Medical Devices Ltd | $150M | -17.5 | -105.7 | -956.0 | — | -72.2 | 1 | BEARISH | -19.2 |
| CYC.AX Cyclopharm Limited | $60M | -2.8 | -79.8 | -118.1 | -50.2 | 27.4 | 3 | BEARISH | -53.9 |
| PNV.AX PolyNovo Limited | $620M | 86.3 | 25.2 | 18.9 | 10.0 | 60.5 | 7 | BEARISH | -37.6 |
| SOM.AX SomnoMed Limited | $70M | -24.0 | -13.2 | 10.2 | -6.4 | 29.0 | 6 | BEARISH | -60.8 |
| COH.AX Cochlear Limited | $8.5B | 57.7 | 29.9 | 34.3 | -1.2 | 11.4 | 6 | BEARISH | -57.3 |
| CALZF Polynovo Limited | $430M | 86.3 | 25.3 | 19.0 | 10.0 | 60.8 | 7 | BEARISH | -34.7 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
MX1.AX vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F